Health Trials

Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

1

Review clinical trials related to Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of GFH009 Monotherapy in Patients with Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

This is a multicentre, open-label phase Ib/II study. The purpose of the study is to assess the efficacy, safety/ tolerability and pharmacokinetic of GFH009 monotherapy in patients with relapsed or refractory peripheral T-cell lymphoma

Participants needed: 95
Trial details
Phase: Phase 1, Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Genfleet Therapeutics (Shanghai) Inc.Updated: Dec 13, 2024Locations: 1
Eligibility criteria

Male or female ≥ 18 years and ≤ 75 years. [+10]

Diagnosis of Cutaneous T-cell lymphoma . [+17]

Read more